BELLO, LORENZO
BELLO, LORENZO
Dipartimento di Oncologia ed Emato-Oncologia
HDAC6 and HDAC8 combined targeting to counteract Glioblastoma Multiforme progression and treatment resistance
2026 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M. Caterina Mione, L. Mollica, P. Viani, A. Pistocchi
Single-cell analysis reveals corticosteroid-associated impairment of tumor-infiltrating NK cells in glioblastoma patients
2026 S. Balin, P. Marzano, A. Limonta, S. Terzoli, M. Simonelli, L. Bello, F. Pessina, B. Savino, J. Mikulak, F. Calcaterra, E. Fontana, M. Locati, D. Mavilio, S. Della Bella
HDAC6 and HDAC8 combined targeting to counteract Glioblastoma Multiforme progression and treatment resistance
2026 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, E. Villa, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M.C. Mione, L. Mollica, A. Pistocchi, P. Viani
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 1: intraoperative recommendations for mapping, monitoring, and decision making
2026 J.K.W. Gerritsen, P. Karschnia, L. Bello, S. Hervey-Jumper, J.S. Young, K. Seidel, D.D. Satoer, O. Schnell, M. Parsons, B.V. Nahed, G. Menna, N. Teske, T.R. Smith, N. Sanai, S.M. Krieg, P. Schucht, M.L.D. Broekman, S. De Vleeschouwer, A.S. Jakola, M.J. Van Den Bent, S.M. Chang, M.A. Vogelbaum, A.J.P.E. Vincent, J. Tonn, M.S. Berger
Towards more effective Glioblastoma Multiforme therapies: HDAC6 and HDAC8 combined targeting
2026 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, S. Albadri, M.C. Mione, L. Mollica, P. Viani, A. Pistocchi
Towards more effective Glioblastoma Multiforme therapies: HDAC6 and HDAC8 combined targeting
2026 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M. Caterina Mione, L. Mollica, P. Viani, A. Pistocchi
A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment
2026 J.K.W. Gerritsen, P. Karschnia, L. Bello, S. Hervey-Jumper, J.S. Young, K. Seidel, D.D. Satoer, O. Schnell, M. Parsons, B.V. Nahed, G. Menna, N. Teske, T.R. Smith, N. Sanai, S.M. Krieg, P. Schucht, M.L.D. Broekman, S. De Vleeschouwer, A.S. Jakola, M.J. Van Den Bent, S.M. Chang, M.A. Vogelbaum, A.J.P.E. Vincent, J. Tonn, M.S. Berger
Associations of supramaximal resection with outcome in glioblastoma across age groups: A report of the RANO resect group
2026 N. Teske, A. Dono, J.S. Young, S.T. Jünger, G. Youssef, L. Häni, T. Sciortino, F. Bruno, J. Dietrich, C.Y. Mau, M. Weller, J. Beck, S. Hervey-Jumper, A.M. Molinaro, S.M. Chang, M. Van Den Bent, M.A. Vogelbaum, M.I. Ruge, D.P. Cahill, R. Rudà, L. Bello, S.J. Grau, O. Schnell, R.Y. Huang, P.Y. Wen, N. Tandon, M.S. Berger, J. Tonn, Y. Esquenazi, P. Karschnia
Automatic and standardized reporting of perioperative MRIs in patients with central nervous system tumors
2026 D. Bouget, M.G. Faanes, A.S. Jakola, F. Barkhof, H. Ardon, L. Bello, M.S. Berger, S.L. Hervey-Jumper, J. Furtner, A.J.S. Idema, B. Kiesel, G. Widhalm, R.N. Tewarie, E. Mandonnet, P.A. Robe, M. Wagemakers, T.R. Smith, P.C. De Witt Hamer, O. Solheim, I. Reinertsen
HDAC8 AND HDAC6 COMBINED INHIBITION: A NEW FRONTIER IN GLIOBLASTOMA TREATMENT
2025 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, D. Giana, A. Pezzotta, A. Marozzi, G. Carullo, L. Sicuro, L. Mollica, L. Bello, G. Campiani, P. Viani, M.C. Mione, A. Pistocchi
HDAC8 and HDAC6 combined inhibition: a new frontier in glioblastoma treatment
2025 G. Galassi, S. Carbone, L. Brioschi, I. Tagliabue, A. Pezzotta, A. Marozzi, G. Carullo, L. Sicuro, L. Mollica, L. Bello, G. Campiani, P. Viani, M. Caterina Mione, A. Pistocchi
Towards more effective Glioblastoma Multiforme therapies: HDAC6 and HDAC8 combined targeting
2025 S. Carbone, G. Galassi, L. Brioschi, I. Tagliabue, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, M. Caterina Mione, L. Mollica, P. Viani, A. Pistocchi
HDAC6 and HDAC8 inhibition enhances the efficacy of Temozolomide by rewiring sphingolipid metabolism and glioma cell fate
2025 I. Tagliabue, L. Brioschi, G. Galassi, S. Carbone, A. Pezzotta, A. Marozzi, L. Mollica, L. Sicuro, L. Bello, G. Campiani, G. Carullo, M. Caterina Mione, A. Pistocchi, P. Viani
HDAC6 and HDAC8 orchestrate sphingolipid metabolic reprogramming to regulate glioma cell fate
2025 I. Tagliabue, L. Brioschi, G. Galassi, S. Carbone, A. Vutera Cuda, A. Pezzotta, G. Carullo, L. Sicuro, L. Bello, A. Marozzi, G. Campiani, L. Mollica, M.C. Mione, A. Pistocchi, P. Viani
Prognostic value of manual versus automatic methods for assessing extents of resection and residual tumor volume in glioblastoma
2025 P. Majewska, R. Holden Helland, A. Ferles, A. Pedersen, I. Kommers, H. Ardon, F. Barkhof, L. Bello, M.S. Berger, T. Dunås, M. Conti Nibali, J. Furtner, S.L. Hervey-Jumper, A.J.S. Idema, B. Kiesel, R. Nandoe Tewarie, E. Mandonnet, D.M.J. Müller, P.A. Robe, M. Rossi, T. Sciortino, T. Aalders, M. Wagemakers, G. Widhalm, A.H. Zwinderman, P.C. De Witt Hamer, R.S. Eijgelaar, L.M. Sagberg, A.S. Jakola, E. Thurin, I. Reinertsen, D. Bouget, O. Solheim
Convergent causal mapping unravels distinct frontal networks for visuospatial selective attention
2025 G. Puglisi, L. Viganò, A. Leonetti, M. Rossi, T. Sciortino, M. Conti Nibali, L.G. Gay, L. Mollica, L. Fornia, G. Cerri, L. Bello
A strategy for multimodal integration of transcriptomics, proteomics, and radiomics data for the prediction of recurrence in patients with IDH-mutant gliomas
2025 T. Chouleur, C. Etchegaray, L. Villain, A. Lesur, T. Ferté, M. Rossi, L. Andrique, C. Simoncini, A. Giacobbi, M. Gambaretti, E. Lopci, B. Fernades, G. Dittmar, R. Bjerkvig, B. Hejblum, R. Thiébaut, O. Saut, L. Bello, A. Bikfalvi
Estimating overall survival of glioblastoma patients using clinical variables, tumor size, and location
2025 A. Ferles, P. Majewska, R. Holden Helland, I. Kommers, A. Pedersen, M. Tranfa, H. Ardon, L. Bello, M.S. Berger, T. Dunås, M.C. Nibali, J. Furtner, S.L. Hervey-Jumper, A.J.S. Idema, B. Kiesel, R.N. Tewarie, E. Mandonnet, P.A. Robe, M. Rossi, T. Sciortino, T. Aalders, M. Wagemakers, G. Widhalm, A.H. Zwinderman, L.M. Sagberg, A.S. Jakola, E. Thurin, I. Reinertsen, D. Bouget, O. Solheim, R.S. Eijgelaar, P.C. De Witt Hamer, F. Barkhof
From non-human to human primates: a translational approach to enhancing resection, safety, and indications in glioma surgery while preserving sensorimotor abilities
2025 M. Gambaretti, L. Viganò, M. Gallo, G. Pratelli, T. Sciortino, L. Gay, M. Conti Nibali, A.L. Gallotti, L. Tariciotti, L. Mattioli, L. Bello, G. Cerri, M. Rossi
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group
2025 P. Karschnia, J.S. Young, G.C. Youssef, A. Dono, L. Häni, T. Sciortino, F. Bruno, S.T. Juenger, N. Teske, J. Dietrich, M. Weller, M.A. Vogelbaum, M. Van Den Bent, J. Beck, N. Thon, J.K.W. Gerritsen, S. Hervey-Jumper, D.P. Cahill, S.M. Chang, R. Rudà, L. Bello, O. Schnell, Y. Esquenazi, M.I. Ruge, S.J. Grau, R.Y. Huang, P.Y. Wen, M.S. Berger, A.M. Molinaro, J. Tonn